Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
At the direction of the U.S. Food and Drug Administration (FDA), Biogen Inc. has added a warning of potential liver injury to the label for its multiple sclerosis medication Tecfidera.
According to the FDA warning, “[c]linically significant cases of liver injury have been reported in patients treated with Tecfidera in the postmarketing setting.
The onset has ranged from a few days to several months after initiation of treatment with Tecfidera.”
Liver injury information can be found in a warning section under prescribing information on the website tecfidera.com.
Tecfidera, formerly known as BG-12, is a fumaric acid derivative that was formulated specifically for use by people with multiple sclerosis.
Although exactly the way it works is not fully understood, it is thought to inhibit immune cells and molecules and may have antioxidant properties to provide protection against damage to the brain and spinal cord.
Common side effects associated with Tecfidera include flushing, usually described as redness, itching, or rash; and stomach problems such as nausea, vomiting, diarrhea, stomach pain, and indigestion.
More severe side effects include allergic reactions; PML, a rare brain infection that leads to death or disability; decreases in white blood cell count; and liver problems.
There have been 14 cases of liver injury reported with Tecfidera use, but the problems resolved when patients stopped taking the medication and none required hospitalization.
Symptoms of liver injury include significant increases above normal of serum aminotransferases and bilirubin, according to Biogen.
Because liver enzyme monitoring is typical with many MS drugs, it is not anticipated that the new warning will present an added burden to prescribing physicians.
It remains to be seen whether or not the warning will temper sales projections for Tecfidera, which is the world’s top-selling MS medication and accounts for about one-third of Biogen’s total revenue.
Biogen recently announced an eight percent increase in the U.S. price of Tecfidera, effective January 1, and experts have forecasted that Tecfidera sales will be more than $4 billion in 2017.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
The California company C&A Naturistics is recalling its AK Forte supplement in response to a recent analysis that found undisclosed drugs in the product. According to the FDA, the company announced the recall last Thursday. The recalled product was sold online via Ebay and Etsy
The FDA warned consumers and health care providers today regarding a serious recall initiated by Staska Pharmaceuticals, Inc. of one lot of their Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL, 50mL vials. The company issued the recall last Thursday after discovering potential contamination
Your Justice, Our Mission TruLaw was founded to solve the problem of access to justice. Our commitment is to educate our audience to make informed decisions throughout the legal process, provide personalized guidance, and deliver meaningful results. Contact Us Meet The Team Trusted legal information